The discovery centers on a protein called RGS4, which the team found acts as a kind of intracellular circuit governing whether pain sensitivity normalizes after an injury or becomes locked in place. In experiments described in the journal Science Signaling, the researchers blocked RGS4 in the dorsal root ganglia, clusters of sensory nerve cells that innervate the lumbar spinal cord. When they did so in experimental models of neuropathic pain, the nervous system recovered from its abnormal, hypersensitive condition. Conversely, when the scientists increased RGS4 levels, otherwise uninjured models became more sensitive to pain, demonstrating that the protein is not merely a passive marker of injury but an active driver of the transition to persistent pain.

The dorsal root ganglia are a logical place for such a switch to reside. These structures contain the cell bodies of sensory neurons that relay touch, temperature, and pain information from the body toward the spinal cord. Because they sit outside the blood-brain barrier’s protective envelope and outside the central nervous system proper, they are more accessible to targeted therapies than circuits deep within the brain. The Boston University team’s finding that RGS4 operates within these sensory nerve cells suggests that the maintenance of chronic pain may depend on molecular changes occurring in the periphery, rather than exclusively on rewiring within the spinal cord or brain.

RGS4 belongs to a family of regulator of G-protein signaling proteins, molecules that modulate how long intracellular signaling pathways remain active after a receptor on the cell surface is stimulated. By accelerating the deactivation of G-protein signaling, RGS proteins shape the intensity and duration of the messages a neuron sends. In the context of nerve injury, the new research indicates that RGS4 activity contributes to maladaptations, molecular and behavioral changes that keep sensory neurons unusually excitable. Venetia Zachariou, PhD, the Edward Avedisian Professor and chair of the department of pharmacology, physiology & biophysics at the school and the study’s corresponding author, explained that one reason pain may become chronic is that the sensory nerves themselves undergo molecular changes that keep them unusually sensitive.

To establish the protein’s role, the researchers used several groups of experimental models in which they could manipulate RGS4 in different ways. In some groups they removed the protein entirely, in others they reduced it specifically in sensory nerve cells, and in still others they increased its levels. This range of approaches allowed them to test whether the effects they observed were genuinely attributable to RGS4 rather than to compensatory developmental changes or off-target effects. They then assessed the functional consequences across a spectrum of chronic pain conditions, including peripheral nerve injury, postoperative pain, inflammatory pain, and chemotherapy-induced nerve damage, a breadth that strengthens the case that RGS4 is a general mechanism of pain chronification rather than a quirk of a single model.

The results carry particular weight because current treatments for chronic pain remain inadequate. Existing painkillers, including opioids such as morphine, largely mask the sensation of pain rather than addressing the biological processes that sustain it, and they can cause significant side effects, including the risk of dependence that has fueled a public health crisis. Many patients with neuropathic pain find little relief from any available medication. The Boston University team argues that the field needs therapies that interrupt the processes causing pain to persist in the first place, rather than simply dampening pain signals after chronic pain has already taken hold.

Zachariou emphasized that the findings point toward exactly that kind of intervention. Inhibition of RGS4, she noted, can be an effective way to manage neuropathic pain conditions and possibly other forms of chronic pain. Because the pathway can be manipulated in sensory nerve cells outside the brain and spinal cord, it may offer opportunities to develop more targeted treatments while potentially limiting effects elsewhere in the nervous system. That peripheral specificity matters enormously for drug development, since medications that act broadly on the central nervous system often produce sedation, cognitive effects, or addiction liability that limit their usefulness.

Importantly, the researchers also found that the main players controlling the maintenance of chronic pain in their experimental models are expressed in human nerve tissue as well. This conservation across species raises the possibility that RGS4 functions the same way in people, a critical prerequisite for translating the work into clinical therapies. While the study itself was conducted in experimental models, the presence of the relevant molecular machinery in human sensory neurons provides a plausible route from bench to bedside, and it suggests that biomarkers based on RGS4 activity could eventually help identify which patients are most likely to benefit from such treatments.

The broader significance of the work lies in its reframing of what chronic pain is. Rather than viewing persistent pain as simply a louder version of acute pain, the research supports a model in which chronic pain is a disease state sustained by specific, potentially reversible molecular adaptations in sensory neurons. Understanding the detailed mechanisms that control the transition from acute to chronic pain, and the maintenance of chronic pathological pain, the researchers argue, would be essential to guide the development of effective and safer medications. If the maladaptations can be reversed, as the RGS4 experiments suggest, then chronic pain may not be a permanent sentence but a treatable condition.

For patients, the hope is that future therapies built on this discovery could do what morphine and other current analgesics cannot: allow the nervous system itself to reset. Rather than simply masking pain after it becomes chronic, Zachariou said, the team hopes this work contributes to therapies that interrupt the biological processes that cause pain to persist in the first place. The findings appear online in Science Signaling, and the research was supported by National Institutes of Health funding including grants R01NS135775, R01NS117101, F31NS115318, and T32GM159592. As the opioid epidemic continues to highlight the dangers of symptomatic pain relief, mechanistic discoveries like this one offer a glimpse of a different future, one in which the circuits that keep pain alive are switched off at their source.

Subject of Research: The role of the RGS4 protein in dorsal root ganglia sensory neurons in the initiation and maintenance of chronic neuropathic pain

Article Title: BU researchers discover intracellular circuit responsible for chronic pain

Article References: BU researchers discover intracellular circuit responsible for chronic pain. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: chronic pain, neuropathic pain, RGS4, dorsal root ganglia, sensory neurons, Boston University School of Medicine, Science Signaling, peripheral nerve injury, pain chronification, drug targets, G-protein signaling, opioid alternatives

That procedure is the lumbar puncture, a technique neurologists perform routinely to sample cerebrospinal fluid for the diagnosis of infections, inflammatory diseases, and a host of other neurological conditions. In an editorial published online in the journal Neurology Education, corresponding author Daniel Harrison, MD, assistant professor of neurology at the school and a neurointensivist at Boston Medical Center, together with his colleague, makes the case that empowering neurologists and neurology trainees to perform ultrasound-assisted lumbar punctures at the bedside is a worthwhile goal. The editorial reviews a study by Grubman et al. that evaluated the possible benefits of the technique in neurology, analyzed previous work in other fields, and described future steps toward more widespread adoption.

The technical logic behind ultrasound guidance for lumbar puncture is straightforward. Traditionally, the procedure relies on anatomical landmarks: the clinician palpates the patient’s spine, identifies the spaces between vertebrae by touch, and inserts a needle into the dural sac to collect fluid. This blind approach works well in many patients, but it can fail in those whose anatomy makes landmarks difficult to identify, including patients with obesity, spinal deformities, or severe degenerative back disease. Failed attempts mean repeated needle insertions, prolonged discomfort, referrals for fluoroscopic or computed tomography guidance, and, critically, delays in diagnosis. Ultrasound changes the equation by allowing the operator to visualize the spinous processes, interspinous spaces, and depth to the dural sac before the needle ever breaks the skin.

Evidence from other specialties suggests the payoff is real. Harrison notes that when studied in other fields, ultrasound-assisted lumbar puncture has resulted in increases in overall and first-pass success rates, with reductions in patient-reported pain scores and possible rates of complications. Anesthesiologists and emergency physicians, who regularly perform neuraxial procedures such as epidural injections and spinal anesthesia, have accumulated much of this evidence. The editorial is candid, however, about a key limitation: data supporting the use of this technique specifically by neurologists and neurology trainees remain limited. Training in point-of-care ultrasound for head, eye, and nerve conditions is improving, but the technology is only moderately used by neurologists managing some neurological conditions, and procedure guidance has not yet become a standard part of the specialty’s toolkit.

The stakes of delay are not abstract. Harrison points to meningitis as a prime example, noting that there is an established association between time to treatment and patient outcomes in that condition. When a patient presents with suspected bacterial meningitis, cerebrospinal fluid analysis is often essential to confirm the diagnosis and guide antimicrobial therapy. Every failed lumbar puncture attempt, every transfer to another service for image-guided sampling, adds time to a clock that is directly linked to morbidity and mortality. The ability of a neurologist or trainee to complete the procedure successfully at the bedside, on the first attempt, with ultrasound assistance, could therefore translate into measurably better outcomes for the sickest patients.

Harrison and his colleague argue that the benefits of ultrasound assistance may be even more pronounced in patients who are overweight or have difficult anatomy. Considering the available data, they suggest that patients who seem most likely to benefit, for example those with the highest body mass indices or severe back disease, should always have lumbar punctures performed with ultrasound assistance, regardless of the discipline of the specialist performing the procedure. This recommendation effectively reframes ultrasound guidance not as an optional refinement but as a standard of care for a defined, high-risk subgroup, a position that, if adopted widely, would have significant implications for training programs and hospital equipment allocation alike.

The editorial also emphasizes that the educational infrastructure for implementation already exists. As Harrison explains, the field knows which competency-based educational tools can be leveraged to maximize the chances of successful implementation in neurology. Point-of-care ultrasound education in other specialties has matured into a well-defined pedagogy, with milestone-based progression, hands-on simulation, supervised scanning, and formal competency assessment. The ACGME’s designation of point-of-care ultrasound as an official graduation milestone in multiple specialties provides a ready-made template that neurology residency programs could adapt, integrating probe skills, image interpretation, and procedure guidance into existing curricula rather than building an educational framework from scratch.

What is missing, according to the researchers, is the kind of evidence that would convince specialty leaders and hospital administrators to invest. The editorial calls for controlled multicenter studies focusing on higher-level outcomes such as trainee performance, patient outcomes, and health care or implementation costs. Such studies would test whether the successes documented in other specialties genuinely translate to neurology, where patient populations, procedure settings, and trainee experience differ. Cost-effectiveness data would be particularly persuasive, since portable ultrasound units represent a capital expense, and departments will want evidence that reduced procedure times, fewer failed attempts, and fewer referrals for image-guided puncture offset the investment.

The editorial’s appearance in Neurology Education is itself meaningful, because it places the argument before the audience best positioned to act: the educators who design residency and fellowship curricula. The Grubman et al. study that the editorial reviews represents an early step in building the neurology-specific evidence base, evaluating the possible benefits of ultrasound-assisted lumbar puncture in the specialty and mapping the path toward broader adoption. If subsequent multicenter trials confirm the pattern seen in other fields, the combination of existing educational tools, clear clinical rationale, and a defined high-benefit patient subgroup could accelerate adoption faster than is typical for new procedural techniques.

For now, the editorial stands as a call to action grounded in cautious optimism. The technique is not new, the supporting evidence from adjacent specialties is substantial, and the clinical scenarios where it matters most, from suspected meningitis to the patient whose body habitus defeats landmark-based approaches, are familiar to every practicing neurologist. What remains is the deliberate work of training, assessment, and study that would turn bedside ultrasound-guided lumbar puncture from an emerging idea into an expected skill. As Harrison and his colleague conclude, empowering neurologists and neurology trainees to perform lumbar punctures at the bedside in the interest of swift diagnosis and treatment is a goal worth pursuing, and the tools to achieve it are already within reach.

Subject of Research: Ultrasound-assisted lumbar puncture training and adoption in neurology

Article Title: Editorial deems empowering neurologists and neurology trainees to perform lumbar punctures at bedside a worthwhile goal

Article References: Editorial deems empowering neurologists and neurology trainees to perform lumbar punctures at bedside a worthwhile goal. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: point-of-care ultrasound, lumbar puncture, neurology education, medical training, bedside procedures, meningitis, ACGME milestones, neurology trainees, ultrasound guidance, Boston University School of Medicine, patient outcomes, Editorial